Crit Care Nurs Q. 2004 Apr-Jun;27(2):113-25. doi: 10.1097/00002727-200404000-00003.
PMID:15137354
Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Mustafa OG, Haq M, Dashora U, Castro E, Dhatariya KK; Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Diabet Med. 2023 Mar;40(3):e15005. doi: 10.1111/dme.15005. Epub 2022 Dec 21.
PMID:36370077
Diabetic ketoacidosis fluid management in children: systematic review and meta-analyses.
Hamud AA, Mudawi K, Shamekh A, Kadri A, Powell C, Abdelgadir I.
Diabetic Ketoacidosis at the Onset of Type 1 Diabetes Mellitus Among Children and Adolescents in Jeddah, Saudi Arabia: A Study From the Emergency Department.
Batwa M, Alharthi L, Ghazal R, Alsulami M, Slaghour R, Aljuhani R, Bakhsh A.
Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM.
Zhang W, Chen J, Bi J, Ding N, Chen X, Wang Z, Jiao Y.
Front Endocrinol (Lausanne). 2023 Jan 4;13:1084441. doi: 10.3389/fendo.2022.1084441. eCollection 2022.
PMID:36686495
Anti-interleukin-21 antibody and liraglutide for the preservation of beta-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors.